Reto Naef
15Patents
3h-index
17Co-inventors
57Inventor score
Filing activity: Sep 27, 1984 → Dec 29, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5177085A | Dihydro-isoquinoline derivatives, processes for their production, pharmaceutical compositions containing them, and their use in treating asthma | Human Necessities | 65 | Expired |
| US5643870A | O-acylated cyclosporins | Human Necessities | 31 | Expired |
| US4980359A | Isoquinoline derivatives and their use | Human Necessities | 16 | Expired |
| US5747506A | Isoquinoline compounds, compositions containing them and their pharmaceutical uses | Chemistry; Metallurgy | 3 | Expired |
| US5852005A | Tetracyclic triterpenes | Chemistry; Metallurgy | 2 | Expired |
| US5925649A | Ascomycins | Chemistry; Metallurgy | 2 | Expired |
| US4585892A | Process for the enantioselective production of .alpha.-alkylated, acyclic .alpha.-aminocarboxylic acids | Chemistry; Metallurgy | 2 | Expired |
| US10570137B2 | 2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7019136B2 | 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US11905293B2 | Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof | Human Necessities | 0 | Active |
| US7361661B2 | 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US11242347B2 | 2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11897890B2 | 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12351585B2 | 2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11155558B2 | Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.